Pacific Biosciences of California Inc (PACB):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Pacific Biosciences of California Inc (PACB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C9987)・商品コード:DATA904C9987
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:30
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥52,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥78,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Pacific Biosciences of California Inc (Pacific Biosciences) designs, develops, and manufactures sequencing instruments for solving complex genetic abnormalities. The company’s product portfolio comprises proprietary Phospholinked nucleotides, sequencing systems, analytical software and consumables. Its products enable the identification of novel genes; characterization of alternatively spliced isoforms in prominent gene families, and targeted sequencing, and provide real-time kinetic data for characterization of epigenomes. Pacific Biosciences’ products are based on its novel single molecule, real-time (SMRT) sequencing technology. It caters to scientific and research communities, government and commercial entities. The company has subsidiaries in the US, Canada, Germany, Japan, China, Singapore, and the UK. Pacific Biosciences is headquartered in Menlo Park, California, the US.

Pacific Biosciences of California Inc (PACB) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pacific Biosciences of California Inc, Medical Devices Deals, 2012 to YTD 2018 8
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Pacific Biosciences of California Raises USD20.5 Million in Venture Funding 10
Equity Offering 11
Pacific Biosciences of California Raises USD69 Million in Public Offering of Shares 11
Pacific Biosciences Raises USD150 Million in Public Offering Of Common Stock 13
Acquisition 15
Illumina to Acquire Pacific Biosciences of California 15
Pacific Biosciences May Sell Itself 17
Pacific Biosciences of California Inc – Key Competitors 18
Pacific Biosciences of California Inc – Key Employees 19
Pacific Biosciences of California Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 02, 2018: Pacific Biosciences of California reports second quarter 2018 financial results 21
Feb 01, 2018: Pacific Biosciences Announces Fourth Quarter and Annual 2017 Financial Results 22
Corporate Communications 23
Jul 31, 2018: Pacific Biosciences Appoints Christian Henry to Board of Directors 23
Legal and Regulatory 24
May 09, 2018: Oxford Nanopore announces favourable outcome in UK and German patent litigation against Pacific Biosciences 24
Feb 08, 2018: Oxford Nanopore Successfully Defends PacBio lawsuit 25
Government and Public Interest 26
Jul 30, 2018: Diversity of Unexpected CRISPR Edits Revealed by SMRT Sequencing 26
Other Significant Developments 27
Jun 06, 2018: Wellcome Sanger Institute Sequences Reference Genomes of 3,000 Dangerous Bacteria 27
May 21, 2018: Phase Genomics and Pacific Biosciences Announce the Release of Co-Developed Genome Assembly Phasing Software – ‘FALCON-Phase’ 28
Mar 15, 2018: Study Demonstrates Potential for SMRT Sequencing to Improve the Safety of Gene Therapy Protocols 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pacific Biosciences of California Inc, Medical Devices Deals, 2012 to YTD 2018 8
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pacific Biosciences of California Raises USD20.5 Million in Venture Funding 10
Pacific Biosciences of California Raises USD69 Million in Public Offering of Shares 11
Pacific Biosciences Raises USD150 Million in Public Offering Of Common Stock 13
Illumina to Acquire Pacific Biosciences of California 15
Pacific Biosciences May Sell Itself 17
Pacific Biosciences of California Inc, Key Competitors 18
Pacific Biosciences of California Inc, Key Employees 19
Pacific Biosciences of California Inc, Subsidiaries 20

List of Figures
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pacific Biosciences of California Inc, Medical Devices Deals, 2012 to YTD 2018 8

★調査レポート[Pacific Biosciences of California Inc (PACB):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C9987)販売に関する免責事項を必ずご確認ください。
★調査レポート[Pacific Biosciences of California Inc (PACB):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆